tiprankstipranks
Nanobiotix (NBTX)
NASDAQ:NBTX

Nanobiotix (NBTX) Financial Statements

31 Followers

Nanobiotix Financial Overview

Nanobiotix's market cap is currently ―. The company's EPS TTM is $-1.718; its P/E ratio is -3.67; Nanobiotix is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 41.40M€ 63.02M€ 83.92M€ 102.34M€ 119.15M
Total Assets€ 59.77M€ 80.62M€ 101.77M€ 123.92M€ 134.03M
Total Debt€ 0.00€ 45.11M€ 46.02M€ 50.72M€ 48.98M
Net Debt€ -41.40M€ -17.91M€ -37.90M€ -51.62M€ -70.17M
Total Liabilities€ -201.02M€ 78.83M€ 74.98M€ 82.48M€ 63.56M
Stockholders Equity€ 256.23M€ 1.79M€ 26.79M€ 41.43M€ 70.47M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

Nanobiotix Earnings and Revenue History

Nanobiotix Debt to Assets

Nanobiotix Cash Flow

Nanobiotix Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis